Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,969,754 Compounds for treating spinal muscular atrophy
The present invention provides compounds of formula (I) ##STR00001## wherein A, R.sup.1, R.sup.2 and R.sup.3 are as described herein, as well as...
US-9,969,753 BCR-ABL diploid inhibitor, synthesizing method therefor, and uses thereof
Disclosed are compounds or pharmaceutically acceptable salts thereof having the following general formula: R-Linker-R. The compounds or pharmaceutically...
US-9,969,752 Inhibitors of HIF prolyl hydroxylase
The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for...
US-9,969,751 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of antimicrobials and antimicrobial-related...
US-9,969,750 Method of producing (3S,11aR)-6,8-dihalo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1- ...
A process for preparing a compound shown by formula (W6): ##STR00001## wherein each Hal is independently chloro or bromo, using a novel process for preparing a...
US-9,969,749 Inhibitors of IRAK4 activity
The present invention relates to inhibitors of IRAK4 of Formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for...
US-9,969,748 Fused bicyclic heteroaromatic derivatives as kinase inhibitors
A series of fused bicyclic heteroaromatic derivatives of formula (IA) or (IB), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase...
US-9,969,747 Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-y- l)acetamide
The present disclosure relates to a crystalline form of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-y- l)acetamide, which is useful...
US-9,969,746 Opioid compounds and their uses
The present invention relates to opioid compounds, especially to C14 esters and ethers of naltrexone and analogs thereof. The present invention also relates to...
US-9,969,745 N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazi- nes as selective NK-3 receptor...
Novel compounds of Formula I ##STR00001## methods of manufacturing the compounds and their use in therapeutic treatments are presented.
US-9,969,744 Compounds for use in cognition improvement
Novel compounds for use in cognition improvement It relates to certain compounds having a polycyclic structure and a --(C.dbd.O)NR.sup.aR.sup.b moiety, wherein...
US-9,969,743 Urea and amide derivatives of aminoalkylpiperazines and use thereof
Provided are compounds represented by the formula: ##STR00001## In which: Y is an unbranched, saturated or unsaturated hydrocarbon chain with 2-5 hydrocarbon...
US-9,969,742 Imidazotriazinone compounds
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9 and pharmaceutically acceptable salt thereof. The present...
US-9,969,741 Pyrazolotriazines as inhibitors of nucleases
The invention provides compounds represented by the structural formula (1): ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in the...
US-9,969,740 Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations
The present invention relates to solid state forms of a p-toluenesulfonic acid salt (PTSA) of the selective PI3K delta inhibitor ...
US-9,969,739 Tricyclic chiral compounds and their use in asymmetric catalysis
The present invention relates to a compound of general Formula (VIII), ##STR00001## the compound having a bowl-shaped conformation, its formation and its use...
US-9,969,738 N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor...
Novel compounds of Formula I ##STR00001## and their use in therapeutic treatments.
US-9,969,737 Fluorescent carbapenems
Chromogenic or fluorescent carbapenems according to formula I, wherein Ar is a mono or disubstituted carbocyclic aromatic group or an optionally mono or...
US-9,969,736 Substituted xanthines and methods of use thereof
Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
US-9,969,735 Process for making tricyclic lactam compounds
Processes are described for the preparation of tricyclic lactam compound of Formula (I), having the structure and intermediates useful for the preparation of...
US-9,969,734 Process for the preparation of spiroheterocyclic pyrrolidine diones
A process for making certain spiroheterocyclic pyrrolidine dione derivatives.
US-9,969,732 Tetrahydroisoquinoline estrogen receptor modulators and uses thereof
Described herein are tetrahydroisoquinoline compounds with estrogen receptor modulation activity or function having the Formula I structure: ##STR00001## and...
US-9,969,731 Heterocyclyl compounds as MEK inhibitors
The present disclosure is related to heteroaryl compounds as MEK inhibitors. These compounds include heteroaryl compounds of formula I, their pharmaceutically...
US-9,969,730 Stable SNS-595 compositions and methods of preparation
Methods of preparing substantially pure SNS-595 substance are disclosed. Also provided are compositions comprising SNS-595 substance that are substantially pure...
US-9,969,729 Imidazopyridine derivatives as modulators of TNF activity
A series of substituted 1H imidazo[4,5-b]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the...
US-9,969,728 Tetrahydroimidazopyridine derivatives as modulators of TNF activity
A series of substituted 5,6,7,8-tetrahydroimidazo[1,2-.alpha.]pyridine derivatives, being potent modulators of human TNF.alpha. activity, are accordingly of...
US-9,969,727 Pyrrolopyridines as kinase inhibitors
Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable...
US-9,969,726 Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof
Provided herein are small molecule active metabotropic glutamate subtype-2 and -3 receptor negative allosteric modulators (NAMs), compositions comprising the...
US-9,969,725 Pharmaceutical salts of an orexin receptor antagonist
The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts...
US-9,969,724 Factor IXa inhibitors
In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or...
US-9,969,723 3-(4-(benzyloxy)phenyl)hex-4-ynoic acid derivative, method of preparing same and pharmaceutical composition for...
The present invention relates to a novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative, a preparation method thereof, and a pharmaceutical composition...
US-9,969,722 Fumagillol derivatives and polymorphs thereof
The present disclosure relates to salts and polymorphs of aminoalkylfumagillol carbamates (e.g., fumagill-6-yl N-(trans-4-aminocyclohexyl)carbamate...
US-9,969,721 Process for the preparation of vilazodone hydrochloride and its amorphous form
The present invention relates to an improved process for the preparation of vilazodone Hydrochloride and a process for preparation of novel pure amorphous form...
US-9,969,720 Compounds useful to treat mycoses
This invention relates to compounds, as defined in the specification and as represented by the compound of formula (I): ##STR00001## that are useful in the...
US-9,969,719 Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
Disclosed is a substituted 2H-pyrazole derivative serving as a selective CDK4/6 inhibitor. Specifically, disclosed is a compound of formula (I) or a...
US-9,969,718 Preparation method for Bemaciclb
Disclosed is an intermediate of bemaciclib (also referred to as abemaciclib) having a structure of Formula II, ##STR00001## and preparation methods therefor....
US-9,969,717 Method for producing substituted anthranilic acid derivatives
The present invention relates to a process for preparing substituted anthranilic acid derivatives of the formula (I) ##STR00001## in which R.sup.1, R.sup.2,...
US-9,969,716 Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof
Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
US-9,969,715 Compounds useful for treating cancer
The present invention relates to a compound of formula (I): ##STR00001## wherein A and A' independently represent a phenylene group or a pyridylene group;...
US-9,969,714 Carboxylic acid compounds useful for inhibiting microsomal prostaglandin E2 synthase-1
The present invention provides compounds of Formula 1, or a pharmaceutically acceptable salts, thereof, where R, X, A, E, and G are as described herein, methods...
US-9,969,713 Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their...
Solid forms comprising 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the solid forms, methods of making the solid ...
US-9,969,712 Process for the preparation of isotopologues of ...
Provided are processes for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,- 6-dione, or a...
US-9,969,711 NK.sub.1 antagonists
A compound having the general structure shown in Formula I: ##STR00001## or pharmaceutically acceptable salts and/or solvates thereof are useful in treating...
US-9,969,710 Heteroaryl compounds as IRAK inhibitors and uses thereof
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
US-9,969,709 Guanidinobenzoic acid ester compound
[Problem] To provide a compound which is useful as an agent for preventing and/or treating kidney diseases. [Means for Solution] The present inventors have...
US-9,969,708 Method for producing glyceric acid carbonate
The present invention relates to a method for preparing a compound of the formula (I) with a specific definition of the substituent R.sub.3 ##STR00001## a...
US-9,969,707 Method for extracting anthocyanin derivatives from a plant source
The present document describes a method for extracting anthocyanin derivatives from a plant source. The method comprises the step of separating a homogenized...
US-9,969,706 Method of producing beraprost
An improved method is described for making single isomers of synthetic benzoprostacyclin analog compounds, in particular the pharmacologically active 314-d...
US-9,969,705 Fused heterocyclic compound
A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity,...
US-9,969,704 Phosphonic acid catalyst in dehydrative cyclization of 5 and 6 carbon polyols with improved color and product...
A process for preparing materials derived from sugar alcohols such that the dehydration products exhibit better accountability and improved color to water-clear...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.